The Limitations of Visual Field Testing in Glaucoma: Frequency, Subjectivity, and What Gets Missed

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/the-limitations-of-visual-field-testing-in-glaucoma-frequency-subjectivity-and-what-gets-missed

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

The Limitations of Visual Field Testing in Glaucoma: Frequency, Subjectivity, and What Gets MissedGlaucoma is a chronic optic nerve disease often called the “silent thief of sight.” It causes gradual, irreversible loss of vision. The main way doctors track glaucoma progression is through visual field (VF) tests: automated perimetry exams that map the patient’s peripheral vision. In theory, these tests let clinicians spot vision loss early and adjust treatment. But in practice, standard visual field testing has important shortcomings. This article discusses why VF tests are often done too infrequently, how their subjective nature and patient factors add noise, and what kinds of vision loss these tests can miss. We will also review research on the test’s reliability and what scientists and doctors do to tell true progression from random fluctuation. Finally, we will highlight new technologies under study and give practical tips for patients and providers to get the most out of visual field exams.Frequency of Visual Field TestingGuidelines vs. Real-World Practice Most glaucoma guidelines stress frequent monitoring, especially soon after diagnosis. For example, expert recommendations suggest newly diagnosed patients get about three VF tests per year in the first two years to establish a reliable baseline and detect “fast progressors” early (). In fact, one modeling study concluded that six tests in two years (i.e. three per year) are needed to reliably measure a typical glaucoma progression rate of ~1 dB/year (). The European Glaucoma Society (EGS) adopted this schedule into its guidelines. However, surveys and audits show that in practice glaucoma patients are tested far less often. In one large UK audit (n≈90,000 patients), VF testing was done on average only once per year (). In the United States, a national insurance-data study found a median frequency of only 0.63 VF tests per year among open-angle glaucoma patients (). Over 75% of patients had less than one test per year, falling short of recommended annual monitoring () (). In other words, most patients go more than a year between fields, even though an earlier analysis suggests annual testing would already delay detection by years (see below). Clinicians often cite constraints on time and resources for the low testing cadence ().Impact of Infrequent TestingWhy does frequency matter? Because glaucoma usually progresses slowly, doctors rely on multiple VF tests over time to detect a meaningful trend. Sparse testing greatly delays awareness of vision loss. For example, Che Hamzah et al. estimate that detecting a loss of 1 dB/year would take about 6 years if fields are done once a year, but only around 2 years if tests are done 3 times/year (). In other words, infrequent fields can leave patients at risk of unnoticed loss. Delays in spotting progression can mean delayed treatment changes — and once nerve fibers die, vision cannot be recovered. In economic modeling, more frequent early testing (3x/year) in high-risk patients was actually cost-effective by catching “fast progressors” sooner (). Nevertheless, many ophthalmologists and clinics do not follow these intensive protocols. UK and US survey data found that provider